EN  |  JP

Pharmaceutical Development Services

CMIC Group pioneered the Contract Research Organization (CRO) business in Japan more than 30 years ago. Since then CMIC has continued as a leading innovator in the industry and has expanded services to encompass the entire pharmaceutical value-chain, including: contract development and manufacturing, healthcare solutions, sales and marketing, Japan market entry solutions and more. We pride ourselves on meeting customers where they are and with exactly what they need to move their products forward.

View our services below by selecting the phase of drug development that you are working in:

Pre-clinical icon pre Clinical icon


clinical Phase icon clinical Phases

Phase I-III

approval icon Drug Approval Support


approval icon post approval

Post-Approval, Sales & Marketing

Press Release cover

DNP and CMIC HOLDINGS Sign Strategic Alliance Agreement Targeting New Value Creation in Medical and Healthcare Field

Read Full Article

Japan’s first and largest CRO continues 30-year evolution to help global sponsors navigate the complex local market

Access Full Interview
Bioanalysis roundtable report

Bioanalytical Method Validation: Challenges and Opportunities of a Globally Harmonized System

Download Full Report

Our Tailored Pharmaceutical Solutions

CMIC, Japan's first and largest Contract Research Organization, offers tailored solutions for pharmaceutical companies, medical device manufacturers, academia, bio-ventures and medical institutions. Using our collective strengths, we offer a broad range of services from preclinical research to practical applications.

non Clinical Research

Japanese Market Entry

Providing full pharmaceutical capabilities for overseas business partners to enter into Japan market.
Learn More
Asia Clinical Trials

Asia Clinical Trials

Supporting our client’s clinical trials throughout the Asia Pacific region. Providing solutions for a range of therapeutic areas, registry study, observational study, phases II/III clinical trials, phase IV clinical trials, post-marketing surveillance.
Learn More
medical device

Medical Device & IVD

Consultation services on regulatory issues for the latest medical devices and in vitro diagnostics (IVD).
Learn More
oncology services

Oncology Drug Development

Specialized oncology staff assists with strategic development planning, including regulatory interaction, conducting clinical studies and post-marketing promotion for companies that wish to enter into the field of oncology.
Learn More
regenerative Medicine icon

Cell & Gene Therapy

Established systems ready to implement and form development strategies and support every stage of the regenerative medicine lifecycle, including regulatory consulting, various nonclinical and clinical studies, and post-marketing.
Learn More
quality Testing

Orphan Drug

OrphanPacific is a pharmaceutical company within CMIC Group, which provides wealth of experience in the field of orphan drugs: regulatory affairs, supply chain management, quality management and marketing strategy planning.
Learn More